EUVIMEDOpdag EUVIMED
Open access · CC BY 4.0

Supplementum 305: Abstracts SwissAnaesthesia 2026, joint annual congress of the Swiss Society for Anaesthesiology and Perioperative Medicine and the Swiss Association for Anaesthesia Care (Interlaken, Switzerland, November 5−7, 2026)

Swiss Society For Anaesthesiology And Perioperative Medicine, Swiss Association For Anaesthesia Care

Swiss Medical Weekly · 2026-11-02 · 156 (11) · 305

DOI: 10.57187/5885 ↗

At a glance

Journal article in Swiss Medical Weekly, published online on 2026-11-02. Written by Swiss Society For Anaesthesiology And Perioperative Medicine and 1 co-authors. The full text is freely available (open access, CC BY 4.0).

AbstractBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background

Neuromuscular blocking agents (NMBA) are used to facilitate tracheal intubation in both adults and children.However, the paediatric population is highly heterogeneous with regard to age, resulting in relevant differences in physiological and pharmacological responses.Consequently, NMBA use, monitoring, and reversal may vary considerably in clinical practice.Although recent guidelines by the European Society of Anaesthesiology and Intensive Care (ESAIC) and the European Society of Paediatric Anaesthesia (ESPA) provide recommendations, real-world practice remains insufficiently characterised.We aimed to identify and characterize self-reported NMBA practice patterns across different European and non-European countries prior to publication of the ESAIC-ESPA guidelines.

Methods

We performed an international, anonymous, crosssectional, web-based survey conducted between 12 November and 12 December 2025 consisting of 36 questions regarding the practice of NMBA.

Results

The survey was accessed by 904 persons from 43 countries, and 874 responses were included in the analysis.Most participants were from Europe (83.5%) and worked in mixed paediatric anaesthesia and intensive care settings (71.2%).Rocuronium was the most used NMBA for routine tracheal intubation (68%, 95%CI 65-71) and for rapid sequence intubation (67%, 95%CI 64-70).NMBA were used "always" or "mostly" before routine intubation in 47% of neonates (≤ 30 days) and 50% of infants (

Cite

APA

Swiss Society For Anaesthesiology And Perioperative Medicine, & Swiss Association For Anaesthesia Care (2026). Supplementum 305: Abstracts SwissAnaesthesia 2026, joint annual congress of the Swiss Society for Anaesthesiology and Perioperative Medicine and the Swiss Association for Anaesthesia Care (Interlaken, Switzerland, November 5−7, 2026). Swiss Medical Weekly, 156(11), 305. https://doi.org/10.57187/5885

Vancouver

Swiss Society For Anaesthesiology And Perioperative Medicine, Swiss Association For Anaesthesia Care. Supplementum 305: Abstracts SwissAnaesthesia 2026, joint annual congress of the Swiss Society for Anaesthesiology and Perioperative Medicine and the Swiss Association for Anaesthesia Care (Interlaken, Switzerland, November 5−7, 2026). Swiss Medical Weekly. 2026;156(11):305. doi:10.57187/5885

BibTeX
@article{SwissSocietyForAnaesthesiologyAndPerioperativeMedicine2026,
  author = {Swiss Society For Anaesthesiology And Perioperative Medicine and Swiss Association For Anaesthesia Care},
  title = {Supplementum 305: Abstracts SwissAnaesthesia 2026, joint annual congress of the Swiss Society for Anaesthesiology and Perioperative Medicine and the Swiss Association for Anaesthesia Care (Interlaken, Switzerland, November 5−7, 2026)},
  journal = {Swiss Medical Weekly},
  year = {2026},
  volume = {156},
  number = {11},
  pages = {305},
  doi = {10.57187/5885}
}
Start for free →